Terms: = Lymphoma AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Treatment
13815 results:
1. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract] [Full Text] [Related]
2. Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.
Hao Z; Fei Y; Chen J; Huang S; Wang L; Yu Y; Bian M; Si Y; Zhang X; Yang X; Zhang B; Wan Y; Zhang Y; Lin G
Hematology; 2024 Dec; 29(1):2344998. PubMed ID: 38666535
[TBL] [Abstract] [Full Text] [Related]
3. Real-life study on the use of response adapted therapy in patients with Hodgkin lymphoma: Results from a multicenter experience.
Zilioli VR; Cencini E; Lorenzo S; Pezzullo L; Merli M; Rivellini F; Muzi C; Emiliano B; Marcheselli L; Luminari S
Hematol Oncol; 2024 May; 42(3):e3273. PubMed ID: 38661120
[TBL] [Abstract] [Full Text] [Related]
4. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
5. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
[TBL] [Abstract] [Full Text] [Related]
6. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
[TBL] [Abstract] [Full Text] [Related]
7. Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
Wang H; Feng J; Liu Y; Qian Z; Gao D; Ran X; Zhou H; Liu L; Wang B; Fang M; Zhou H; Huang Z; Tao S; Chen Z; Su L; Su H; Yang Y; Xie X; Wu H; Sun P; Hu G; Liang A; Li Z
Signal Transduct Target Ther; 2024 Apr; 9(1):99. PubMed ID: 38627366
[TBL] [Abstract] [Full Text] [Related]
8. [Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma].
Xing TY; Wang WT; Shen HR; Wu JZ; Yin H; Li Y; Wang L; Liang JH; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):163-169. PubMed ID: 38604793
[No Abstract] [Full Text] [Related]
9. Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy.
McQuilten ZK; Weinkove R; Thao LTP; Crispin P; Degelia A; Dendle C; Gilbertson M; Johnston A; Keegan A; Pepperell D; Pullon H; Reynolds J; van Tonder T; Trotman J; Waters N; Wellard C; Weston H; Morrissey CO; Wood EM
Blood Adv; 2024 Apr; 8(7):1787-1795. PubMed ID: 38592710
[TBL] [Abstract] [Full Text] [Related]
10. Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
Chen MF; Song Z; Yu HA; Sequist LV; Lovly CM; Mitchell EP; Moscow JA; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Umemura Y; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2024 Apr; 8():e2300454. PubMed ID: 38591867
[TBL] [Abstract] [Full Text] [Related]
11. treatment of
Kanu JE; Soldera J
World J Gastroenterol; 2024 Mar; 30(9):1213-1223. PubMed ID: 38577188
[TBL] [Abstract] [Full Text] [Related]
12. Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
Alias H; Mohd Ranai N; Lau SCD; de Sonneville LMJ
Sci Rep; 2024 Apr; 14(1):7915. PubMed ID: 38575744
[TBL] [Abstract] [Full Text] [Related]
13. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.
Fang HW; Tseng PL; Hu TH; Wang JH; Hung CH; Lu SN; Chen CH
Virol J; 2024 Apr; 21(1):79. PubMed ID: 38570803
[TBL] [Abstract] [Full Text] [Related]
14. Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018.
Alfaar AS; Yousef YA; W Wilson M; Hassanain O; Kakkassery V; Moustafa M; Kunbaz A; Esmael A; Strauß O
Sci Rep; 2024 Apr; 14(1):7886. PubMed ID: 38570585
[TBL] [Abstract] [Full Text] [Related]
15. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
16. Clinical features of intussusception in children secondary to small bowel tumours: a retrospective study of 31 cases.
Wang L; Zhang H; Wang D; Shen Q; Huang L; Liu T
BMC Pediatr; 2024 Apr; 24(1):227. PubMed ID: 38561715
[TBL] [Abstract] [Full Text] [Related]
17. Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders.
Wagenpfeil J; Hoß K; Henkel A; Kütting D; Luetkens JA; Feldmann G; Brossart P; Attenberger UI; Pieper CC
Clin Exp Med; 2024 Mar; 24(1):63. PubMed ID: 38554229
[TBL] [Abstract] [Full Text] [Related]
18. Disseminated Enterovirus Infection in a Patient Affected by Follicular lymphoma Treated with Obinutuzumab: A Case Report and a Narrative Review of the Literature.
Lupia T; Corcione S; Staffilano E; Bosio R; Curtoni A; Busca A; De Rosa FG
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541221
[No Abstract] [Full Text] [Related]
19. Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).
Hude Dragičević I; Bašić-Kinda S; Markotić H; Morić-Perić M; Dujmović D; Radman I; Dreta B; Dotlić S; Ilić I; Galunić Bilić L; Dobrenić M; Kralik M; Aurer I
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541156
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia.
Brigitha LJ; Mondelaers V; Liu Y; Albertsen BK; Zalewska-Szewczyk B; Rizzari C; Kotecha RS; Pieters R; Huitema ADR; van der Sluis IM
Pharm Res; 2024 Apr; 41(4):711-720. PubMed ID: 38538970
[TBL] [Abstract] [Full Text] [Related]
[Next]
